Nicolas Duverger

7.4k total citations · 3 hit papers
67 papers, 6.2k citations indexed

About

Nicolas Duverger is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nicolas Duverger has authored 67 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 23 papers in Molecular Biology and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nicolas Duverger's work include Cholesterol and Lipid Metabolism (28 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Lipoproteins and Cardiovascular Health (17 papers). Nicolas Duverger is often cited by papers focused on Cholesterol and Lipid Metabolism (28 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Lipoproteins and Cardiovascular Health (17 papers). Nicolas Duverger collaborates with scholars based in France, United States and Belgium. Nicolas Duverger's co-authors include Patrice Denèfle, Bart Staels, Jean‐Charles Fruchart, H. Bryan Brewer, Florence Emmanuel, Marie Rosier, Gerd Assmann, Jean‐François Deleuze, Catherine Fiévet and José Manuel Fernández‐Real and has published in prestigious journals such as Science, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Nicolas Duverger

66 papers receiving 6.1k citations

Hit Papers

Tangier disease is caused by mutations in the gene encodi... 1999 2026 2008 2017 1999 2001 1999 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Duverger France 38 3.3k 2.9k 1.4k 1.3k 1.0k 67 6.2k
Bernardo L. Trigatti Canada 34 2.8k 0.9× 2.4k 0.8× 1.0k 0.7× 971 0.7× 927 0.9× 93 5.6k
Omar L. Francone United States 34 3.6k 1.1× 2.5k 0.9× 1.3k 0.9× 1.6k 1.2× 451 0.4× 71 5.2k
Marcelo Amar United States 44 2.8k 0.9× 1.9k 0.7× 1.4k 1.0× 1.0k 0.8× 591 0.6× 85 5.2k
Pieter H.E. Groot Netherlands 38 1.6k 0.5× 1.8k 0.6× 1.2k 0.8× 1.0k 0.8× 1.1k 1.1× 91 5.1k
Rajendra K. Tangirala United States 37 1.9k 0.6× 2.2k 0.8× 568 0.4× 963 0.7× 1.9k 1.8× 44 5.6k
Bryan Laffitte United States 20 5.1k 1.6× 4.2k 1.5× 771 0.5× 2.6k 1.9× 1.1k 1.1× 32 7.4k
Carrie L. Welch United States 33 2.2k 0.7× 2.8k 1.0× 659 0.5× 983 0.7× 1.8k 1.8× 64 6.3k
Mary G. Sorci‐Thomas United States 38 1.8k 0.6× 1.8k 0.6× 1.2k 0.8× 535 0.4× 1.0k 1.0× 85 4.4k
Michael R. Briggs United States 20 1.8k 0.6× 4.5k 1.5× 588 0.4× 689 0.5× 428 0.4× 25 6.4k
Zemin Yao Canada 45 1.7k 0.5× 2.6k 0.9× 1.6k 1.1× 551 0.4× 921 0.9× 115 6.7k

Countries citing papers authored by Nicolas Duverger

Since Specialization
Citations

This map shows the geographic impact of Nicolas Duverger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Duverger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Duverger more than expected).

Fields of papers citing papers by Nicolas Duverger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Duverger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Duverger. The network helps show where Nicolas Duverger may publish in the future.

Co-authorship network of co-authors of Nicolas Duverger

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Duverger. A scholar is included among the top collaborators of Nicolas Duverger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Duverger. Nicolas Duverger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furman, Christophe, Zhengyu Luo, Kenneth Walsh, et al.. (2002). Systemic tissue inhibitor of metalloproteinase‐1 gene delivery reduces neointimal hyperplasia in balloon‐injured rat carotid artery. FEBS Letters. 531(2). 122–126. 30 indexed citations
2.
Bettan, Mickaël, Florence Emmanuel, Raphaël Darteil, et al.. (2000). High-Level Protein Secretion into Blood Circulation after Electric Pulse-Mediated Gene Transfer into Skeletal Muscle. Molecular Therapy. 2(3). 204–210. 96 indexed citations
3.
Mackness, M., Nathalie Hennuyer, Bharti Mackness, et al.. (2000). Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits. Biochemical and Biophysical Research Communications. 269(1). 232–236. 69 indexed citations
4.
Langer, Claus, Nicolas Duverger, Florence Emmanuel, et al.. (1999). Apolipoprotein A-I(R151C)Paris is defective in activation of lecithin:cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux. Journal of Molecular Medicine. 77(8). 614–622. 33 indexed citations
5.
Rust, Stephan, Marie Rosier, Harald Funke, et al.. (1999). Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nature Genetics. 22(4). 352–355. 1189 indexed citations breakdown →
6.
Peelman, Frank, Berlinda Vanloo, Óscar Pérez‐Méndez, et al.. (1999). Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT). Protein Engineering Design and Selection. 12(1). 71–78. 29 indexed citations
7.
Lambert, Gilles, Berlinda Vanloo, Didier Rouy, et al.. (1998). The C‐terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high‐density lipoproteins. European Journal of Biochemistry. 253(1). 328–338. 22 indexed citations
8.
Liu, Geng, Katherine J. D. A. Excoffon, Janet E. Wilson, et al.. (1998). Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.. PubMed. 21(4-5). 172–85. 4 indexed citations
9.
Rouy, Didier, Nicolas Duverger, Florence Emmanuel, et al.. (1998). Apolipoprotein(a) Yeast Artificial Chromosome Transgenic Rabbits. Journal of Biological Chemistry. 273(2). 1247–1251. 37 indexed citations
10.
Peelman, Frank, N Vinaimont, Berlinda Vanloo, et al.. (1998). A proposed architecture for lecithin cholesterol acyl transferase (LCAT): Identification of the catalytic triad and molecular modeling. Protein Science. 7(3). 587–599. 82 indexed citations
11.
Masson, David, Nicolas Duverger, Florence Emmanuel, & Laurent Lagrost. (1997). Differential Interaction of the Human Cholesteryl Ester Transfer Protein with Plasma High Density Lipoproteins (HDLs) from Humans, Control Mice, and Transgenic Mice to Human HDL Apolipoproteins. Journal of Biological Chemistry. 272(39). 24287–24293. 13 indexed citations
12.
Lebuffe, Gilles, Agnès Boullier, Anne Tailleux, et al.. (1997). Endothelial Derived Vasorelaxation Is Impaired in Human APO A-I Transgenic Rabbits. Biochemical and Biophysical Research Communications. 241(1). 205–211. 15 indexed citations
13.
Liu, Guoqing, Katherine J. D. A. Excoffon, Patrick Benoit, et al.. (1997). Efficient Adenovirus-Mediated Ectopic Gene Expression of Human Lipoprotein Lipase in Human Hepatic (HepG2) Cells. Human Gene Therapy. 8(2). 205–214. 11 indexed citations
14.
Duverger, Nicolas, Günter Tremp, Jean‐Michel Caillaud, et al.. (1996). Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV. Science. 273(5277). 966–968. 217 indexed citations
15.
Skarlatos, Sonia I., et al.. (1995). Cholesterol efflux from human monocyte-derived macrophages in the presence of LpA-I:A-II. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1270(1). 19–25. 11 indexed citations
16.
Staels, Bart, Nicolas Duverger, Anne Tailleux, et al.. (1995). Tissue-specific Expression of the Human Gene for Lecithin: Cholesterol Acyltransferase in Transgenic Mice Alters Blood Lipids, Lipoproteins and Lipases towards a Less Atherogenic Profile. European Journal of Biochemistry. 230(2). 567–575. 49 indexed citations
17.
Klein, Hanns‐Georg, Nicolas Duverger, John J. Albers, et al.. (1995). In Vitro Expression of Structural Defects in the Lecithin-Cholesterol Acyltransferase Gene. Journal of Biological Chemistry. 270(16). 9443–9447. 24 indexed citations
18.
Rader, Daniel J., Katsunori Ikewaki, Nicolas Duverger, et al.. (1994). Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.. Journal of Clinical Investigation. 93(1). 321–330. 98 indexed citations
19.
Rader, D J, Katsunori Ikewaki, Nicolas Duverger, et al.. (1993). Very low high-density lipoproteins without coronary atherosclerosis. The Lancet. 342(8885). 1455–1458. 51 indexed citations
20.
Klein, Hanns‐Georg, Silvia Santamarina-Fojo, Nicolas Duverger, et al.. (1993). Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.. Journal of Clinical Investigation. 92(1). 479–485. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026